Moberg Pharma AB (publ)
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products for skin diseases in Sweden, the United States, and internationally. It develops MOB-015, which is under Phase III clinical trial for the treatment of nail fungus treatment; and BUPI, a lozenge with bupivacaine intended for pain relief in association with inflammation and ulceration of the oral mucous membranes. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was founded in 2006 and is headquartered in Bromma, Sweden. Show More...
-
Website http://www.mobergpharma.se
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 34.14 SEK
-
Last Updated 25-04-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2009-12 2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 TTM Earnings Per Share SEK -4.45 -5.08 -0.82 3.68 -1.01 0.95 1.78 2.25 0.64 1.14 31.9 Dividends SEK Payout Ratio % * Shares Mil 3.0 6.0 8.0 10.0 11.0 13.0 14.0 15.0 18.0 17.0 18.0 Book Value Per Share * SEK 63.05 Free Cash Flow Per Share * SEK Return on Assets % -83.74 -130.16 -12.18 19.19 -4.11 3.89 6.75 4.01 0.91 1.6 46.21 Financial Leverage (Average) 1.17 18.01 1.2 1.58 1.35 1.18 1.13 2.19 2.21 2.11 1.05 Return on Equity % -106.67 -200.87 -16.48 28.09 -5.98 4.86 7.78 7.14 2.0 3.46 67.22 Return on Invested Capital % -104.6 -192.15 -19.57 22.58 -4.51 4.75 7.64 6.09 4.02 4.09 48.63 Interest Coverage -573.56 -27.82 -227.0 52.52 -6.08 13.6 76.97 3.35 1.32 1.71 2.13 Current Ratio 7.23 1.01 5.85 1.68 1.15 2.23 2.67 2.96 3.17 3.77 19.83 Quick Ratio 7.08 0.92 5.41 1.49 0.98 1.92 2.11 2.38 2.77 3.31 19.83 Debt/Equity 0.010 0.22 0.16 0.08 0.010 1.05 1.07 1.0 0.010